Jan Basile to Blood Pressure
This is a "connection" page, showing publications Jan Basile has written about Blood Pressure.
Connection Strength
2.949
-
Determining the relative antihypertensive potency and relative cardiovascular risk reduction associated with different thiazide and thiazide-type diuretics. J Clin Hypertens (Greenwich). 2013 Jun; 15(6):359-61.
Score: 0.272
-
Treating the black hypertensive in 2010: achieve lower targets while awaiting more definitive evidence. J Clin Hypertens (Greenwich). 2011 Jan; 13(1):1-4.
Score: 0.233
-
Is there accord in ACCORD? Lower blood pressure targets in type 2 diabetes does not lead to fewer cardiovascular events except for reductions in stroke. J Clin Hypertens (Greenwich). 2010 Jul 01; 12(7):472-7.
Score: 0.226
-
Identifying and managing factors that interfere with or worsen blood pressure control. Postgrad Med. 2010 Mar; 122(2):35-48.
Score: 0.221
-
Angiotensin receptor blockers: role in hypertension management, cardiovascular risk reduction, and nephropathy. South Med J. 2009 Oct; 102(10 Suppl):S1-S12.
Score: 0.215
-
Rationale for fixed-dose combination therapy to reach lower blood pressure goals. South Med J. 2008 Sep; 101(9):918-24.
Score: 0.199
-
Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report? J Investig Med. 2003 Nov; 51(6):373-85.
Score: 0.142
-
How We Got Where We Are in Blood Pressure Targets. Curr Hypertens Rep. 2021 06 10; 23(6):33.
Score: 0.121
-
Uncontrolled Hypertension in an Elderly Man on Multiple Antihypertensive Drugs. Hypertension. 2020 12; 76(6):1658-1663.
Score: 0.116
-
Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement From the American Heart Association and American Medical Association. Circulation. 2020 07 28; 142(4):e42-e63.
Score: 0.113
-
Cardiovascular Outcomes According to Systolic Blood Pressure in Patients With and Without Diabetes: An ACCOMPLISH Substudy. J Clin Hypertens (Greenwich). 2016 Apr; 18(4):299-307.
Score: 0.084
-
Ambulatory blood pressure monitoring to diagnose hypertension--an idea whose time has come. J Am Soc Hypertens. 2016 Feb; 10(2):89-91.
Score: 0.082
-
Renal sympathetic denervation for blood pressure control: a review of the current evidence and ongoing studies. J Clin Hypertens (Greenwich). 2014 May; 16(5):331-41.
Score: 0.073
-
Analysis of recent papers in hypertension. Initial combination therapy provides more prompt blood pressure control and reduces cardiovascular events but remains underutilized. J Clin Hypertens (Greenwich). 2013 Aug; 15(8):523-5.
Score: 0.069
-
Analysis of recent papers in hypertension: nighttime administration of at least one antihypertensive medication is associated with better blood pressure control and cardiovascular outcomes in patients with type 2 diabetes or chronic kidney disease. J Clin Hypertens (Greenwich). 2013 Jan; 15(1):2-4.
Score: 0.066
-
Mortality and morbidity during and after the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Clin Hypertens (Greenwich). 2012 Jan; 14(1):20-31.
Score: 0.062
-
New British guidelines mandate ambulatory blood pressure monitoring to diagnose hypertension in all patients: not ready for prime time in the United States. J Clin Hypertens (Greenwich). 2011 Nov; 13(11):785-6.
Score: 0.062
-
Comparison of aliskiren/hydrochlorothiazide combination therapy with hydrochlorothiazide monotherapy in older patients with stage 2 systolic hypertension: results of the ACTION study. J Clin Hypertens (Greenwich). 2011 Mar; 13(3):162-9.
Score: 0.059
-
Combination angiotensin receptor blocker-neutral endopeptidase inhibitor provides additive blood pressure reduction over angiotensin receptor blocker alone. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):809-12.
Score: 0.057
-
Largest meta-analysis to date suggests that patients at risk for cardiovascular disease events derive benefit from antihypertensive therapy regardless of baseline blood pressure and to reduce vascular events, lowering blood pressure is more important than choice of antihypertensive drug class. J Clin Hypertens (Greenwich). 2009 Dec; 11(12):743-5.
Score: 0.054
-
Blood pressure control by drug group in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). J Clin Hypertens (Greenwich). 2008 Oct; 10(10):751-60.
Score: 0.050
-
Analysis of recent papers in hypertension. J Clin Hypertens (Greenwich). 2007 May; 9(5):396.
Score: 0.045
-
Fixed-dose combination therapy in the treatment of hypertension: ready for prime time. South Med J. 2007 Apr; 100(4):343-4.
Score: 0.045
-
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension. J Clin Hypertens (Greenwich). 2004 Jan; 6(1):18-25.
Score: 0.036
-
Analysis of recent papers in hypertension. Need for more aggressive blood pressure control in diabetes. J Clin Hypertens (Greenwich). 2003 Sep-Oct; 5(5):352-3.
Score: 0.035
-
Systolic blood pressure elevation: it's where the action is. Drugs Aging. 2003; 20(4):287-8.
Score: 0.034
-
Hypertension 2001: pearls for the clinician. South Med J. 2001 Nov; 94(11):1054-7.
Score: 0.031
-
Combination agents as a means of improving adherence and other aspects of the sixth Joint National Committee Report. South Med J. 2000 May; 93(5):534-6.
Score: 0.028
-
Hypertension and Its Complications in a Young Man With Autoimmune Disease. Hypertension. 2017 04; 69(4):536-544.
Score: 0.022
-
Highly interactive multi-session programs impact physician behavior on hypertension management: outcomes of a new CME model. J Clin Hypertens (Greenwich). 2011 Feb; 13(2):97-105.
Score: 0.015
-
Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med. 2010 Apr 29; 362(17):1575-85.
Score: 0.014
-
Rationale and design for the blood pressure intervention of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Am J Cardiol. 2007 Jun 18; 99(12A):44i-55i.
Score: 0.011
-
Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network. J Clin Hypertens (Greenwich). 2006 Dec; 8(12):879-86.
Score: 0.011
-
Clinical events in high-risk hypertensive patients randomly assigned to calcium channel blocker versus angiotensin-converting enzyme inhibitor in the antihypertensive and lipid-lowering treatment to prevent heart attack trial. Hypertension. 2006 Sep; 48(3):374-84.
Score: 0.011
-
Excessive alcohol consumption and hypertension: clinical implications of current research. J Clin Hypertens (Greenwich). 2005 Jun; 7(6):346-51.
Score: 0.010
-
Hypertension and heart failure. Roundtable discussion. J Clin Hypertens (Greenwich). 2004 Jun; 6(6):326-32.
Score: 0.009
-
Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of hypertension in older adults with and without glucose disorders: a report from the ALLHAT study. J Clin Hypertens (Greenwich). 2004 Mar; 6(3):116-25.
Score: 0.009
-
Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care. 2001 Apr; 24(4):654-8.
Score: 0.007